Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Jens K. Habermann"'
Autor:
Francesca Pistollato, Gregor Burkhart, Pierre Deceuninck, Camilla Bernasconi, Sergio Di Virgilio, Luca Emili, Anne-Charlotte Fauvel, Luisa Ferreira Bastos, Annalisa Gastaldello, Chiara Gerardi, Jens K. Habermann, Ioan Hanes, Christina Kyriakopoulou, Uma Lanka, Paolo Lauriola, Hugh Laverty, Benoit G. C. Maisonneuve, Milena Mennecozzi, Francesco Pappalardo, Roberta Pastorino, Vilma Radvilaite, Erwin L. Roggen, Helder Constantino
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
In the past decade, significant European calls for research proposals have supported translational collaborative research on non-communicable and infectious diseases within the biomedical life sciences by bringing together interdisciplinary and multi
Externí odkaz:
https://doaj.org/article/57a57f6114c44caaaa7cb172d799d368
Autor:
Friederike Praus, Axel Künstner, Thorben Sauer, Michael Kohl, Katharina Kern, Steffen Deichmann, Ákos Végvári, Tobias Keck, Hauke Busch, Jens K. Habermann, Timo Gemoll
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Colorectal cancer (CRC) is one of the most prevalent cancers, with over one million new cases per year. Overall, prognosis of CRC largely depends on the disease stage and metastatic status. As precision oncology for patients with
Externí odkaz:
https://doaj.org/article/a3b31ca7db6f42b1a6ed7d76b3f8c000
Autor:
Christoph Dumke, Timo Gemoll, Martina Oberländer, Sandra Freitag-Wolf, Christoph Thorns, Axel Glaessgen, Rinse Klooster, Silvère M. van der Maarel, Jerker Widengren, Christian Doehn, Gert Auer, Jens K. Habermann
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Current prostate cancer risk classifications rely on clinicopathological parameters resulting in uncertainties for prognostication. To improve individual risk stratification, we examined the predictive value of selected proteins with respect
Externí odkaz:
https://doaj.org/article/68a3591cd68b4f21a9b0964e6eb15294
Autor:
Sushant Patkar, Kerstin Heselmeyer-Haddad, Noam Auslander, Daniela Hirsch, Jordi Camps, Daniel Bronder, Markus Brown, Wei-Dong Chen, Rachel Lokanga, Darawalee Wangsa, Danny Wangsa, Yue Hu, Annette Lischka, Rüdiger Braun, Georg Emons, B. Michael Ghadimi, Jochen Gaedcke, Marian Grade, Cristina Montagna, Yuri Lazebnik, Michael J. Difilippantonio, Jens K. Habermann, Gert Auer, Eytan Ruppin, Thomas Ried
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-16 (2021)
Abstract Background Many carcinomas have recurrent chromosomal aneuploidies specific to the tissue of tumor origin. The reason for this specificity is not completely understood. Methods In this study, we looked at the frequency of chromosomal arm gai
Externí odkaz:
https://doaj.org/article/5ccb78cdd26b4762976deb16d27ec9ec
Autor:
Timo Gemoll, Elena Miroll, Oliver Klein, Annette Lischka, Murat Eravci, Christoph Thorns, Jens K. Habermann
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background One major hallmark of colorectal cancers (CRC) is genomic instability with its contribution to tumor heterogeneity and therapy resistance. To facilitate the investigation of intra-sample phenotypes and the de novo identification o
Externí odkaz:
https://doaj.org/article/e178032f73024c6dbda38eec43effe97
Autor:
Rüdiger Braun, Scott Ronquist, Darawalee Wangsa, Haiming Chen, Lena Anthuber, Timo Gemoll, Danny Wangsa, Vishal Koparde, Cynthia Hunn, Jens K. Habermann, Kerstin Heselmeyer-Haddad, Indika Rajapakse, Thomas Ried
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 4, Pp 401-412 (2019)
Chromosomal aneuploidy is a defining feature of carcinomas and results in tumor-entity specific genomic imbalances. For instance, most sporadic colorectal carcinomas carry extra copies of chromosome 7, an aneuploidy that emerges already in premaligna
Externí odkaz:
https://doaj.org/article/35d0a8085ffe429fa3c4e14eb3f33649
Autor:
Thorben Sauer, Giulia Facchinetti, Michael Kohl, Justyna M. Kowal, Svitlana Rozanova, Julia Horn, Hagen Schmal, Ivo Kwee, Arndt-Peter Schulz, Sonja Hartwig, Moustapha Kassem, Jens K. Habermann, Timo Gemoll
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 5, p 2568 (2022)
Mesenchymal stem cells (MSCs) gain an increasing focus in the field of regenerative medicine due to their differentiation abilities into chondrocytes, adipocytes, and osteoblastic cells. However, it is apparent that the transformation processes are e
Externí odkaz:
https://doaj.org/article/6ad5eb6590ee4ebe9f2fa93bb3d91a95
Autor:
Anna-Sophie Liegmann, Kerstin Heselmeyer-Haddad, Annette Lischka, Daniela Hirsch, Wei-Dong Chen, Irianna Torres, Timo Gemoll, Achim Rody, Christoph Thorns, Edward Michael Gertz, Hendrik Alkemade, Yue Hu, Jens K. Habermann, Thomas Ried
Publikováno v:
Cancers, Vol 13, Iss 13, p 3366 (2021)
Purpose: Older breast cancer patients are underrepresented in cancer research even though the majority (81.4%) of women dying of breast cancer are 55 years and older. Here we study a common phenomenon observed in breast cancer which is a large inter-
Externí odkaz:
https://doaj.org/article/53edf81c4cd64c63ba02106be319267c
Autor:
Timo Gemoll, Sarah Strohkamp, Svitlana Rozanova, Christian Röder, Sonja Hartwig, Holger Kalthoff, Stefan Lehr, Abdou ElSharawy, Jens K. Habermann
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 15, p 3343 (2021)
The authors wish to make the following corrections to this paper [...]
Externí odkaz:
https://doaj.org/article/5d41c5eee6464da8bcb0d6c88a05709a
Autor:
Timo Gemoll, Sarah Strohkamp, Svitlana Rozanova, Christian Röder, Sonja Hartwig, Holger Kalthoff, Stefan Lehr, Abdou ElSharawy, Jens K. Habermann
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 5, p 1429 (2020)
Solid tumor biopsies are the current standard for precision medicine. However, the procedure is invasive and not always feasible. In contrast, liquid biopsies, such as serum enriched for extracellular vesicles (EVs) represent a non-invasive source of
Externí odkaz:
https://doaj.org/article/f1cb8186262a4a648ed53d805d3fbc62